Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Stroke as an emergency].

M Arnold1

  • 1Neurologische Universitätsklinik und -poliklinik, Inselspital Bern. marcel.arnold@insel.ch

Praxis
|September 25, 2002
PubMed
Summary
This summary is machine-generated.

Acute ischemic stroke treatment includes thrombolysis within 3-6 hours. This intervention reduces long-term disability by 11-15% in eligible patients, with aspirin as a key alternative.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An open letter: In solidarity with all children suffering in wars; to all who hold or share a concern for the wellbeing of children.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025
Same author

Response: Why solidarity with all children suffering in wars is not antisemitic.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025
Same author

Bunch length measurement setup for femtocoulomb bunch charges at the superconducting Darmstadt electron linear accelerator S-DALINAC.

The Review of scientific instruments·2025
Same author

Multichannel laser diode to polymer waveguide array coupling with a double-aspheric lens.

Applied optics·2023
Same author

Intra-Arterial Thrombolysis is Associated with Delayed Reperfusion of Remaining Vessel Occlusions following Incomplete Thrombectomy.

AJNR. American journal of neuroradiology·2023
Same author

Applications of machine learning in animal and veterinary public health surveillance.

Revue scientifique et technique (International Office of Epizootics)·2023
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Emergency Medicine

Context:

  • Acute ischemic stroke is a time-sensitive medical emergency requiring prompt intervention.
  • Current treatment guidelines focus on reperfusion therapies and secondary prevention.

Purpose:

  • To summarize the critical treatment windows and therapeutic options for acute ischemic stroke.
  • To highlight the role of thrombolysis and pharmacotherapy in managing stroke patients.
  • To emphasize the importance of addressing complications in acute stroke care.

Summary:

  • Intravenous thrombolysis is recommended within 3 hours, while intra-arterial thrombolysis extends to 6 hours post-symptom onset for acute ischemic stroke.
  • Thrombolysis offers an 11-15% absolute reduction in long-term disability for selected patients.

Related Experiment Videos

  • Aspirin is the preferred agent when thrombolysis is contraindicated; heparin is reserved for high-recurrence risk cases.
  • Effective management of acute stroke necessitates vigilant diagnosis and treatment of associated medical and neurological complications.

    • Impact:

    • Improved patient outcomes through timely and appropriate stroke interventions.
    • Reduced long-term disability and enhanced quality of life for stroke survivors.
    • Optimized clinical decision-making regarding thrombolytic therapy and pharmacotherapy selection.